This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Karo Pharma Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 1/6
Wichtige Informationen
104.8%
Verhältnis von Schulden zu Eigenkapital
SEK 8.65b
Verschuldung
| Zinsdeckungsgrad | 0.2x |
| Bargeld | SEK 353.10m |
| Eigenkapital | SEK 8.26b |
| Gesamtverbindlichkeiten | SEK 10.24b |
| Gesamtvermögen | SEK 18.49b |
Jüngste Berichte zur Finanzlage
Recent updates
Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: KA6N's short term assets (SEK1.7B) exceed its short term liabilities (SEK626.0M).
Langfristige Verbindlichkeiten: KA6N's short term assets (SEK1.7B) do not cover its long term liabilities (SEK9.6B).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: KA6N's net debt to equity ratio (100.5%) is considered high.
Schulden abbauen: KA6N's debt to equity ratio has increased from 59.5% to 104.8% over the past 5 years.
Schuldendeckung: KA6N's debt is not well covered by operating cash flow (5.9%).
Zinsdeckung: KA6N's interest payments on its debt are not well covered by EBIT (0.2x coverage).